Jiaping Li
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 5%
Papers in
- Hepatology 63
- Hepatocellular Carcinoma Treatment and Prognosis 61
- Liver Disease and Transplantation 10
-
- Renal cell carcinoma treatment 13
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Wenzhe Fan (64 shared papers)Pierre Layrolle (2 shared papers)Yingqiang Zhang (24 shared papers)Klaas de Groot (2 shared papers)Baogang Peng (6 shared papers)Jianyong Yang (18 shared papers)Jizhou Tan (11 shared papers)Pamela Habibović (7 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Frontiers in Oncology (5 papers)Journal of Vascular and Interventional Radiology (5 papers)Oncotarget (5 papers)PLoS ONE (4 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Jiaping Li
192 papers receiving 4.3k citations
Jiaping Li's Hit Papers
Peers
Comparison fields: 5 of 172
- Hepatology 1.3k
- Cancer Research 464
- Oncology 674
- Pathology and Forensic Medicine 427
- Pulmonary and Respiratory Medicine 710
Countries citing papers authored by Jiaping Li
This map shows the geographic impact of Jiaping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Li more than expected).
Fields of papers citing papers by Jiaping Li
This network shows the impact of papers produced by Jiaping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Li. The network helps show where Jiaping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 262 |
| 2 | 2004 | 173 | |
| 3 | 2003 | 172 | |
| 4 | 2020 | 166 | |
| 5 | 2020 | 139 | |
| 6 | 2009 | 133 | |
| 7 | TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma Hit paper breakdown → | 2023 | 121 |
| 8 | 2012 | 104 | |
| 9 | 2019 | 101 | |
| 10 | 2020 | 93 | |
| 11 | 2009 | 82 | |
| 12 | 2012 | 80 | |
| 13 | 2015 | 79 | |
| 14 | 2019 | 75 | |
| 15 | 2021 | 68 | |
| 16 | 2011 | 67 | |
| 17 | 2016 | 65 | |
| 18 | 2018 | 61 | |
| 19 | 2015 | 60 | |
| 20 | 2023 | 56 |
About Jiaping Li
Jiaping Li is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Pathology and Forensic Medicine, having authored 199 papers that have together received 4.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (61 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Cancer Mechanisms and Therapy (22 papers), Renal cell carcinoma treatment (13 papers), Liver Disease Diagnosis and Treatment (11 papers), Bone Tissue Engineering Materials (10 papers), Liver Disease and Transplantation (10 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Hepatology (1.3k citations), Cancer Research (464 citations), Oncology (674 citations), Pathology and Forensic Medicine (427 citations) and Pulmonary and Respiratory Medicine (710 citations). Jiaping Li has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Wenzhe Fan, Pierre Layrolle, Yingqiang Zhang, Klaas de Groot, Baogang Peng, Jianyong Yang, Jizhou Tan, Pamela Habibović, Ting Liu and Yu Wang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Journal of Vascular and Interventional Radiology, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.